Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Servier
Servier
Eli Lilly and Company
Tango Therapeutics, Inc.
Hoosier Cancer Research Network
M.D. Anderson Cancer Center
Filamon LTD
Essen Biotech
Eli Lilly and Company
Black Diamond Therapeutics, Inc.
LigaChem Biosciences, Inc.
Incyte Corporation
Cambridge University Hospitals NHS Foundation Trust
First People's Hospital of Hangzhou
Southwest Hospital, China
Shenzhen BinDeBio Ltd.
BBB-Therapeutics B.V.
Novartis
Memorial Sloan Kettering Cancer Center